The short version. Procerin delivers therapeutic-dose oral saw palmetto (1,500 mg/day of standardized berry extract) with a small but real human-RCT evidence base for mild-to-moderate male pattern hair loss, at roughly $30 per month. The effect is substantially smaller than finasteride’s, and the “natural DHT blocker” marketing implies a drug-equivalence the evidence doesn’t support. Worth considering only if you’ve specifically decided against finasteride and want a low-risk oral adjunct to topical minoxidil — and only if you’re comfortable paying the brand premium over a generic 320 mg standardized saw palmetto from any supplement retailer.
Procerin is a men-targeted hair-loss supplement and topical system that has been on the market since the early 2000s, sold primarily through direct-to-consumer channels and Amazon. The brand is built around an oral saw palmetto tablet positioned as a “natural DHT blocker” — explicitly framed as a non-prescription alternative to finasteride — and a companion topical spray or foam applied to the scalp. It is one of the oldest surviving brands in the natural-hair-loss-supplement category, which is an achievement of marketing longevity rather than clinical substantiation.
Our editorial position: Procerin’s active ingredient is real, its theoretical mechanism is plausible, and its clinical effect in men with androgenetic alopecia is small enough that a reader choosing it over finasteride is making a meaningful compromise. For readers who cannot or will not take finasteride, Procerin is a defensible placeholder. For everyone else, it is not.
What Procerin actually is
Procerin is produced by Speedwinds Nutrition, a Long Island-based nutraceutical company that markets a handful of supplement products through DTC and Amazon channels. The hair-loss line includes two products:
Procerin Tablets — an oral supplement combining saw palmetto (the principal active, at approximately 1,500 mg per daily dose across three tablets), CJ-9 (a proprietary blend containing magnesium, zinc, vitamin B6, and various supporting nutrients), and a small amount of gotu kola, muira puama, and eleuthero (folk-medicine herbals). The stated mechanism is oral 5-alpha reductase inhibition via saw palmetto, positioned as a “natural alternative to Propecia.”
Procerin XT Topical Foam — a leave-in scalp foam containing azelaic acid, green tea extract, caffeine, and a set of supporting botanicals, applied once or twice daily.
The brand sells both products separately and bundled, with monthly cost ranging from $30 for tablets alone to $70+ for the bundled system with subscription discounts applied.
The saw palmetto question
The entire clinical premise of Procerin rests on oral saw palmetto’s ability to inhibit 5-alpha reductase — the enzyme that converts testosterone to dihydrotestosterone (DHT), which drives androgenetic alopecia. Finasteride (Propecia) inhibits the same enzyme by a different mechanism, and the comparison Procerin’s marketing invites is: both inhibit 5-alpha reductase, so both should produce similar hair-loss outcomes.
The honest answer: yes, saw palmetto inhibits 5-alpha reductase. It does so weakly. Multiple in-vitro studies have measured inhibition levels in the 30-40% range at therapeutic concentrations, compared to 95%+ for finasteride. That difference matters enormously for clinical outcome, because the relationship between enzyme inhibition and hair preservation is not linear — the threshold for meaningful follicle protection sits at a level of DHT suppression that saw palmetto does not reliably achieve.
The clinical evidence for oral saw palmetto in androgenetic alopecia is limited. A small 2012 trial (60 men) comparing saw palmetto to finasteride found both produced improvement over six months, with finasteride producing substantially larger effects — about 38% improvement versus 6% for saw palmetto in the saw palmetto group (numbers vary by trial). Other small trials have shown similar patterns: saw palmetto produces a measurable but modest effect that is consistently smaller than finasteride.
For a reader with active pattern hair loss, the practical implication is that choosing saw palmetto over finasteride trades approximately 80% of the expected clinical benefit for avoidance of finasteride’s side-effect profile (primarily: a small risk of sexual side effects in a minority of users). Whether that trade is the right one depends on the specific reader — but it is the trade, and Procerin’s marketing does not frame it that way.
The CJ-9 complex and supporting actives
The “CJ-9” proprietary blend is what Procerin uses to differentiate itself from generic saw palmetto supplements. The components — magnesium, zinc, B6 — are real nutrients with real but generic roles in metabolism and hair health; they are not hair-specific interventions. The herbal supporting actives (gotu kola, muira puama, eleuthero) have folk-medicine hair-growth associations and no blinded trial evidence in this indication.
A reader who wants what Procerin tablets are actually delivering — therapeutic-dose saw palmetto plus basic hair-supporting micronutrients — could assemble the same thing from a generic saw palmetto supplement ($8–15/month) plus a basic multivitamin ($5/month) for a fraction of the Procerin tablet price.
The XT topical foam
Procerin XT is a competent topical foam with legitimate supporting actives (caffeine has weak evidence for hair-shaft thickness; azelaic acid has theoretical but unproven topical 5-alpha reductase activity; green tea extract has in-vitro evidence). It is not a minoxidil equivalent. Users choosing Procerin XT over minoxidil are making the same kind of trade as users choosing saw palmetto over finasteride — accepting a meaningfully smaller effect in exchange for a more “natural” positioning.
The foam is pleasant to use, doesn’t leave residue, and is well-tolerated. For a reader already committed to minoxidil and looking for an adjunct, it is defensible. For a reader using it as a minoxidil replacement, it is not.
Who Procerin might be a reasonable fit for
Men who have specifically decided against finasteride — whether because of the sexual side-effect concerns, the commitment to a prescription drug, or a general preference for natural products — and who want some intervention that addresses the androgen pathway. In this specific case, Procerin (or any equivalent therapeutic-dose saw palmetto supplement) is better than nothing.
Men using Procerin as an adjunct to a minoxidil + Nizoral regimen, where the supplement is providing additional weak 5-alpha reductase modulation on top of the primary treatment backbone. The incremental benefit is modest but real.
Men who cannot take finasteride for medical reasons (which in 2026 is a small group — finasteride’s contraindications are narrow).
Who it is not the right fit for
Men with active, progressing hair loss who have not tried finasteride and do not have a specific reason to refuse it. The expected outcome of finasteride is substantially larger, and a conversation with a primary care physician or dermatologist is the responsible next step. Choosing Procerin as an alternative without that conversation is a trade made in the dark.
Men with advanced pattern hair loss (Norwood V or higher). Neither Procerin nor finasteride regrows already-miniaturized follicles; the intervention needs to happen earlier, or the conversation shifts to transplantation.
Anyone expecting Procerin’s marketing to describe the product accurately. The “natural alternative to Propecia” framing elides the effect-size difference in a way that matters for real clinical decisions.
Side effects and durability
Procerin tablets are well-tolerated. The most common reported side effects are mild gastrointestinal symptoms in the first week or two, usually resolved by taking tablets with food. A small proportion of users with very sensitive androgen systems report mild libido effects similar to those sometimes associated with finasteride, but at lower rates — consistent with the weaker enzyme inhibition.
Procerin XT foam is well-tolerated topically. Scalp irritation is uncommon.
Durability: like all androgen-pathway interventions, the effect persists only with continued use. Discontinuation returns the user to their pre-treatment trajectory within three to six months.
Our recommendation
If you are a man with active pattern hair loss and you have not yet considered finasteride, a conversation with a primary-care physician or dermatologist about finasteride is the first step — not Procerin. The evidence case is substantially stronger, the cost is comparable (generic finasteride is cheap), and the side-effect profile is better understood than the marketing narrative around finasteride suggests.
If you have specifically decided against finasteride, Procerin is an option, but it is worth knowing that generic saw palmetto extract at equivalent therapeutic doses (300-600 mg standardized extract twice daily) costs a fraction of Procerin’s tablet price and delivers the same active. The CJ-9 complex is not meaningfully differentiated.
For the topical side, topical minoxidil (generic 5% foam) delivers substantially more clinical value than Procerin XT and costs roughly the same. If you want a natural-positioning topical, Lipogaine Big 5 delivers more useful actives (ketoconazole, caffeine, biotin, saw palmetto) than Procerin XT at a similar price.
The case for Procerin as a product line is thinner than the case for any of the alternatives we’ve ranked higher. It is not a scam. It is a marketing-heavy wrapper around an active ingredient with real but modest clinical effect, at a price that does not earn its premium.
This review was last evaluated against current evidence and re-priced on April 22, 2026. It supersedes our earlier versions. For the comparative context, see our flagship hub. For the minoxidil evaluation, see our Rogaine review. For how we evaluate products, see our methodology.